NCT07055243: To Assess Safety of Mitapivat and Provide Proof of Concept of the Efficacy of the Drug in Patients With RBC Membranopathies or CDAII.
- State
- Under way
- Phase
- Phase 2
- People
- 9 taking part
- Started
- 20 Oct 2025
- Primary completion
- Oct 2029
- Arms
- Mitapivat
- Results
- None posted
- 8 Jul 2025: Trial registered
- 20 Oct 2025: Trial started